Cell Death and Diabetes: A Conversation with Feroz Papa
In recent years, researchers have learned that beta cells of the pancreas die in patients with type 2 diabetes...
University of California San Francisco
Give to UCSFIn recent years, researchers have learned that beta cells of the pancreas die in patients with type 2 diabetes...
A nationwide study of over 280,000 women showed that postmenopausal women who are overweight or obese have advanced breast cancer at significantly higher rates than women of normal weight or less than normal weight.
Katherine Flores will be honored at a gala awards dinner in New York City on Dec. 4 at the New York Public Library.
Patients with heart disease who are depressed are more likely to smoke, not exercise and not take heart medications correctly than those who are not depressed, thereby putting themselves at greater risk for stroke, heart attack, heart failure, and death, according to a five-year study of over one thousand heart patients led by a researcher at the San Francisco VA Medical Center.
The 19th annual Macy’s Tree Lighting Ceremony, benefiting UCSF Children’s Hospital. Macy’s partners with UCSF each year to raise funds for the Children’s Hospital by selling lights to adorn the 80-foot-tall Shasta Fir. Over the last five years, nearly $700,000 has been raised for UCSF’s pediatric palliative care program – Compass Care – which supports families whose children have life-threatening illnesses.
UCSF hosted nearly 100 fourth-graders from San Francisco’s E.R. Taylor Elementary School to learn about the connection between attending college and becoming a health care professional.
UCSF will go completely smoke-free tomorrow, November 20, which is Great American Smoke-out Day.
Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to research conducted at the University of California, San Francisco. The drugs – imatinib (marketed as Gleevec) and sunitinib (marketed as Sutent) – were found to put type 1 diabetes into remission in 80 percent of the test mice and work permanently in 80 percent of those that go into remission.
A class of miniscule molecules called microRNAs has become a major focus of biomedical research. Now, UCSF scientists have identified multiple members of this class that enable embryonic stem cells to divide, and thus proliferate, much more rapidly than the mature, or specialized, cells of the adult body.